For example, several TNF receptor superfamily (TNFRSF)/ligands such as CD40/CD40L and TWEAK/FN14 also participate in glial cell‐mediated central/neuronal inflammatory diseases such as Alzheimer's disease and MS 31, 32 and are considered as a potential therapeutic target. This evidence concerns the gene CD40 and myeloid sarcoma.